ID

38781

Beschreibung

A Safety, Pharmacokinetics and Pharmacodynamics Study of RO6811135 in Patients With Type 2 Diabetes Mellitus; ODM derived from: https://clinicaltrials.gov/show/NCT01789788

Link

https://clinicaltrials.gov/show/NCT01789788

Stichworte

Versionen (1)
  1. 03.11.19 03.11.19 -
Rechteinhaber

See clinicaltrials.gov

Hochgeladen am

3. November 2019

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Diabetes Mellitus, Type 2 NCT01789788

Englisch

Eligibility Diabetes Mellitus, Type 2 NCT01789788

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
adult patients, 18 to 65 years of age, inclusive
Beschreibung

Adult | Age

Datentyp

boolean

Alias
UMLS CUI [1]
C0001675
UMLS CUI [2]
C0001779
type 2 diabetes mellitus according to who criteria diagnosed for at least 3 months prior to screening
Beschreibung

Non-Insulin-Dependent Diabetes Mellitus WHO classification | Non-Insulin-Dependent Diabetes Mellitus Disease length

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011860
UMLS CUI [1,2]
C4267671
UMLS CUI [2,1]
C0011860
UMLS CUI [2,2]
C0872146
on stable dose of metformin for at least 2 months prior to screening
Beschreibung

Metformin Dose Stable

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0025598
UMLS CUI [1,2]
C0178602
UMLS CUI [1,3]
C0205360
fasting plasma glucose during the screening period </= 240 mg/dl
Beschreibung

Plasma fasting glucose measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0583513
hemoglobin a1c (hba1c) levels at screening >/= 6.5% and </= 10.5%
Beschreibung

Hemoglobin A1c measurement

Datentyp

boolean

Alias
UMLS CUI [1]
C0474680
evidence of insulin secretory capacity at screening
Beschreibung

Insulin Capacity secretory

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0021641
UMLS CUI [1,2]
C1516240
UMLS CUI [1,3]
C1327616
body mass index (bmi) 27 to 42 kg/m2, inclusive
Beschreibung

Body mass index

Datentyp

boolean

Alias
UMLS CUI [1]
C1305855
females of child-bearing potential and males with female partners of child-bearing potential must agree to use effective contraception as defined by protocol
Beschreibung

Childbearing Potential Contraceptive methods | Gender Partner Childbearing Potential Contraceptive methods

Datentyp

boolean

Alias
UMLS CUI [1,1]
C3831118
UMLS CUI [1,2]
C0700589
UMLS CUI [2,1]
C0079399
UMLS CUI [2,2]
C0682323
UMLS CUI [2,3]
C3831118
UMLS CUI [2,4]
C0700589
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
type 1 diabetes
Beschreibung

Diabetes Mellitus, Insulin-Dependent

Datentyp

boolean

Alias
UMLS CUI [1]
C0011854
acquired or secondary forms of diabetes such as those resulting from pancreatic surgery/injury, cystic fibrosis related diabetes
Beschreibung

Diabetes Mellitus Acquired | Secondary diabetes mellitus | Diabetes Mellitus Due to Pancreatic surgery | Diabetes Mellitus Due to Injury of pancreas | Cystic fibrosis related diabetes

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0011849
UMLS CUI [1,2]
C0439661
UMLS CUI [2]
C0271640
UMLS CUI [3,1]
C0011849
UMLS CUI [3,2]
C0678226
UMLS CUI [3,3]
C2033062
UMLS CUI [4,1]
C0011849
UMLS CUI [4,2]
C0678226
UMLS CUI [4,3]
C0273163
UMLS CUI [5]
C2242728
history of acute metabolic complications such as diabetic ketoacidosis or state of hyperosmolar hyperglycemia
Beschreibung

Complications Metabolic | Diabetic Ketoacidosis | Hyperglycemia hyperosmolar

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009566
UMLS CUI [1,2]
C0311400
UMLS CUI [2]
C0011880
UMLS CUI [3]
C0745095
evidence or history of clinically significant diabetic complications such as clinically severe diabetic peripheral neuropathy, clinically significant nephropathy as judged by the investigator, or pre-proliferative/proliferative diabetic retinopathy as judged by the investigator
Beschreibung

Complications of Diabetes Mellitus | Diabetic peripheral neuropathy Severe | Kidney Disease | Preproliferative diabetic retinopathy | Proliferative diabetic retinopathy

Datentyp

boolean

Alias
UMLS CUI [1]
C0342257
UMLS CUI [2,1]
C0740447
UMLS CUI [2,2]
C0205082
UMLS CUI [3]
C0022658
UMLS CUI [4]
C0339473
UMLS CUI [5]
C0154830
history of severe symptomatic hypoglycemia (requiring assistances of a third party) within 6 months prior to screening
Beschreibung

Hypoglycemia Severe Symptomatic | Assistance Required

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020615
UMLS CUI [1,2]
C0205082
UMLS CUI [1,3]
C0231220
UMLS CUI [2,1]
C1269765
UMLS CUI [2,2]
C1514873
history or presence of clinically significant concomitant disease or disorder
Beschreibung

Comorbidity Clinical Significance

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0009488
UMLS CUI [1,2]
C2826293
hemoglobin level below the lower limit of reference range at screening
Beschreibung

Hemoglobin low

Datentyp

boolean

Alias
UMLS CUI [1]
C0162119
pregnant or lactating women
Beschreibung

Pregnancy | Breast Feeding

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
history of anaphylaxis or severe systemic hypersensitivity or allergic reactions
Beschreibung

Anaphylaxis | Severe allergy Systemic | Allergic Reaction

Datentyp

boolean

Alias
UMLS CUI [1]
C0002792
UMLS CUI [2,1]
C2945656
UMLS CUI [2,2]
C0205373
UMLS CUI [3]
C1527304
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Diabetes Mellitus, Type 2 NCT01789788

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Adult | Age
Item
adult patients, 18 to 65 years of age, inclusive
boolean
C0001675 (UMLS CUI [1])
C0001779 (UMLS CUI [2])
Non-Insulin-Dependent Diabetes Mellitus WHO classification | Non-Insulin-Dependent Diabetes Mellitus Disease length
Item
type 2 diabetes mellitus according to who criteria diagnosed for at least 3 months prior to screening
boolean
C0011860 (UMLS CUI [1,1])
C4267671 (UMLS CUI [1,2])
C0011860 (UMLS CUI [2,1])
C0872146 (UMLS CUI [2,2])
Metformin Dose Stable
Item
on stable dose of metformin for at least 2 months prior to screening
boolean
C0025598 (UMLS CUI [1,1])
C0178602 (UMLS CUI [1,2])
C0205360 (UMLS CUI [1,3])
Plasma fasting glucose measurement
Item
fasting plasma glucose during the screening period </= 240 mg/dl
boolean
C0583513 (UMLS CUI [1])
Hemoglobin A1c measurement
Item
hemoglobin a1c (hba1c) levels at screening >/= 6.5% and </= 10.5%
boolean
C0474680 (UMLS CUI [1])
Insulin Capacity secretory
Item
evidence of insulin secretory capacity at screening
boolean
C0021641 (UMLS CUI [1,1])
C1516240 (UMLS CUI [1,2])
C1327616 (UMLS CUI [1,3])
Body mass index
Item
body mass index (bmi) 27 to 42 kg/m2, inclusive
boolean
C1305855 (UMLS CUI [1])
Childbearing Potential Contraceptive methods | Gender Partner Childbearing Potential Contraceptive methods
Item
females of child-bearing potential and males with female partners of child-bearing potential must agree to use effective contraception as defined by protocol
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0079399 (UMLS CUI [2,1])
C0682323 (UMLS CUI [2,2])
C3831118 (UMLS CUI [2,3])
C0700589 (UMLS CUI [2,4])
Item Group
C0680251 (UMLS CUI)
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes
boolean
C0011854 (UMLS CUI [1])
Diabetes Mellitus Acquired | Secondary diabetes mellitus | Diabetes Mellitus Due to Pancreatic surgery | Diabetes Mellitus Due to Injury of pancreas | Cystic fibrosis related diabetes
Item
acquired or secondary forms of diabetes such as those resulting from pancreatic surgery/injury, cystic fibrosis related diabetes
boolean
C0011849 (UMLS CUI [1,1])
C0439661 (UMLS CUI [1,2])
C0271640 (UMLS CUI [2])
C0011849 (UMLS CUI [3,1])
C0678226 (UMLS CUI [3,2])
C2033062 (UMLS CUI [3,3])
C0011849 (UMLS CUI [4,1])
C0678226 (UMLS CUI [4,2])
C0273163 (UMLS CUI [4,3])
C2242728 (UMLS CUI [5])
Complications Metabolic | Diabetic Ketoacidosis | Hyperglycemia hyperosmolar
Item
history of acute metabolic complications such as diabetic ketoacidosis or state of hyperosmolar hyperglycemia
boolean
C0009566 (UMLS CUI [1,1])
C0311400 (UMLS CUI [1,2])
C0011880 (UMLS CUI [2])
C0745095 (UMLS CUI [3])
Complications of Diabetes Mellitus | Diabetic peripheral neuropathy Severe | Kidney Disease | Preproliferative diabetic retinopathy | Proliferative diabetic retinopathy
Item
evidence or history of clinically significant diabetic complications such as clinically severe diabetic peripheral neuropathy, clinically significant nephropathy as judged by the investigator, or pre-proliferative/proliferative diabetic retinopathy as judged by the investigator
boolean
C0342257 (UMLS CUI [1])
C0740447 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0022658 (UMLS CUI [3])
C0339473 (UMLS CUI [4])
C0154830 (UMLS CUI [5])
Hypoglycemia Severe Symptomatic | Assistance Required
Item
history of severe symptomatic hypoglycemia (requiring assistances of a third party) within 6 months prior to screening
boolean
C0020615 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0231220 (UMLS CUI [1,3])
C1269765 (UMLS CUI [2,1])
C1514873 (UMLS CUI [2,2])
Comorbidity Clinical Significance
Item
history or presence of clinically significant concomitant disease or disorder
boolean
C0009488 (UMLS CUI [1,1])
C2826293 (UMLS CUI [1,2])
Hemoglobin low
Item
hemoglobin level below the lower limit of reference range at screening
boolean
C0162119 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Anaphylaxis | Severe allergy Systemic | Allergic Reaction
Item
history of anaphylaxis or severe systemic hypersensitivity or allergic reactions
boolean
C0002792 (UMLS CUI [1])
C2945656 (UMLS CUI [2,1])
C0205373 (UMLS CUI [2,2])
C1527304 (UMLS CUI [3])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video